Knight Jeff E.

CIK 00018810071 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001881007

Recent Transactions

31 trades

Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.17/sh−6,801→ 87,852 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.83/sh−361→ 87,491 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-02-20+65,000→ 65,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-20+43,000→ 94,653 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-11-22$56.52/sh−501→ 51,653 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-15$23.98/sh+17,499→ 70,079 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-07-15−2,887→ 20,213 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-15$20.02/sh+2,887→ 72,966 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-15$55.00/sh−27,000→ 51,653 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-15$19.64/sh+5,687→ 78,653 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-07-15−5,687→ 85,313 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-07-15−17,499→ 112,501 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-26$44.38/sh−956→ 52,580 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-22$45.39/sh−2,359→ 52,580 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-22−30,000→ 130,000 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-22$44.22/sh−30,000→ 54,939 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-22$23.98/sh+30,000→ 84,939 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-18$38.14/sh−4,283→ 54,939 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-04+87,000→ 87,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-04+23,000→ 59,222 total
Other
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-20$14.98/sh+931→ 36,222 total
Other
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-05-22$14.98/sh+891→ 35,291 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-16$17.12/sh−587→ 34,400 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2023-03-01+91,000→ 91,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-01+29,500→ 34,987 total
Other
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-11-20$15.16/sh+537→ 5,487 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-07-26$20.70/sh−1,152→ 4,950 total
Other
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-05-20$17.44/sh+1,152→ 6,102 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-02-28+4,950→ 4,950 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2022-02-28+23,100→ 23,100 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2021-09-01+160,000→ 160,000 total

Companies

Crinetics Pharmaceuticals, Inc.
Chief Operating Officer
$CRNX

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov